recombinant mil-6 (PeproTech)
PeproTech is a verified supplier 
90
Structured Review
PeproTech
recombinant mil-6
Recombinant Mil 6, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mil-6/mil+6/pmc10994929-254-48-52
Average 90 stars, based on 1 article reviews
Recombinant Mil 6, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mil-6/mil+6/pmc10994929-254-48-52
Average 90 stars, based on 1 article reviews
recombinant mil-6 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
FACS:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Cell Culture:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Recombinant:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Expressing:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and In Vitro:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Transfection:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Positive Control:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Flow Cytometry:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Clinical Proteomics:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Labeling:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Injection:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and Control:Article Title: Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 + T cells in murine models of inflammation Article Snippet: FACS-sorted CD44 lo CD5 lo Ly6C − , CD44 lo CD5 hi Ly6C − , and CD44 lo CD5 hi Ly6C + CD8 + T N cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorp TM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Article Snippet: Tumor-derived cytokines, such as interleukin (IL)-6, function in the context of tumor-to-host interactions, and their functions in immune-compromised hosts need to be addressed in the light of everincreasing number of patients under immunosuppression.. We studied the effects, in immune-comprised animals, of tumor-derived IL-6 on tumor growth using an experimental tumor vaccination model. Murine mammary carcinoma FM3A clone 25 (CL25) cells, which neither produce IL-6 nor express IL-6 receptors, were used. cDNA for murine IL-6 (mIL-6) was introduced to the CL25 cells, resulting in a high-producer (mIL-6H) clone.. In the severe combined immune-deficient (SCID) mice, the inoculation 3 weeks earlier of mIL-6H to a dorsal flank site suppressed the growth of the CL25 cells at the opposite flank site; a tumor-derived IL-6-mediated vaccination effect occurred. Article Title: Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression Article Snippet: FACS-sorted CD44loCD5loLy6C−, CD44loCD5hiLy6C−, and CD44loCD5hiLy6C+ CD8+ TN cells were cultured in anti-CD3ε (2.5 μg/ml) (clone 145-2C11) and anti-CD28 (1 μg/ml) (clone 37.51) coated Nunc MaxiSorpTM Flat-Bottom Plate with Article Title: Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Article Snippet: In order to evaluate the effects of mIL-6 on the in vitro growth of CL25 cells, Article Title: Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK Article Snippet: The recombinant mIL-6 and Article Title: CRTAM controls residency of gut CD4 + CD8 + T cells in the steady state and maintenance of gut CD4 + Th17 during parasitic infection Article Snippet: 2 × 10 5 cells were activated with Article Title: NF-κB1 p105 regulates T-cell homeostasis and prevent chronic inflammation Article Snippet: The recombinant mIL-6 and Article Title: Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1 Article Snippet: Recombinant mIL-6 (216-16), mTNF-α (315-01A), and |